MarketPeel
Pricing
…
Chief Business Officer
Andrew Hollman Meyer
Mon, Feb 3, 2025
Feb 3
exercised or converted securities in
JANX
3,334
shares @ $4.21
Increased holdings by
+4.10%
Net across this filing:
0.00%
(+0 shares)
Option Exercise
Sale tied to a same-time option exercise
JANX
Janux Therapeutics, Inc.
Healthcare
Biotechnology
1D
0.00%
1W
+6.95%
1M
+13.44%
3M
+20.76%
6M
—
1Y
—
Recent insider activity at JANX
Jun 2
Janeen Noel Doyle
Sold
$56.94k
May 11
Maria Dobek
Sold
$28.88k
Jan 2
David Alan Campbell
Sold
$110.83k
Jan 2
Maria Dobek
Sold
$20.07k
Jan 2
Andrew Hollman Meyer
Sold
$25.80k
Jan 2
Thomas Diraimondo
Sold
$34.39k
Jan 2
Charles M. Winter
Sold
$32.97k
Jan 2
Zachariah Mciver
Sold
$37.26k
Full JANX profile →
Andrew Hollman Meyer’s trading history →
FREE · DAILY · 6 AM ET
The morning brief, before the bell.
One short email. Insider buys, congressional trades, and plain-English analysis.
Subscribe
Feedback